Alto Neuroscience (ANRO) Share-based Compensation (2023 - 2026)

Alto Neuroscience (ANRO) has 4 years of Share-based Compensation data on file, last reported at $190000.0 in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 90.35% year-over-year to $190000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.8 million (down 135.31% YoY), and the FY2024 full-year result was $5.2 million, up 81.46% from the prior year.
• Share-based Compensation rose to $190000.0 in Q1 2026, from -$6.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.2 million in Q3 2025 to a low of -$6.2 million in Q4 2025.
• A 4-year average of $693916.7 and a median of $1.2 million in 2023 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation surged 350.21% in 2024 and slumped 90.35% in 2026, its largest moves.
• Tracing ANRO's Share-based Compensation over 4 years: stood at $606000.0 in 2023, then jumped by 94.55% to $1.2 million in 2024, then tumbled by 622.65% to -$6.2 million in 2025, then jumped by 103.08% to $190000.0 in 2026.
• Business Quant data shows ANRO's Share-based Compensation at $190000.0 in Q1 2026, -$6.2 million in Q4 2025, and $2.2 million in Q3 2025.